maprotiline has been researched along with trimipramine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (30.43) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Medina-Hernández, MJ; Quiñones-Torrelo, C; Sagrado, S; Villanueva-Camañas, RM | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cardoso, FC; Duggan, PJ; Kuiper, MJ; Lewis, RJ; Schmit, M; Tuck, KL | 1 |
| Casas Carnicero, J; Fernández de la Gandara, F; Velasco Martin, A | 1 |
| Chang, H; Elie, R; Familamiri, P; McClure, DJ; Pecknold, JC | 1 |
| Baumann, P; Cuendet, C; Eap, CB | 1 |
| Joffe, RT; Richter, MA | 1 |
| Hauser, K; Häusler, A; Meeker, JB | 1 |
| Dominguez, RA | 1 |
| Settle, EC | 1 |
| Blier, P; De Montigny, C; Mongeau, R | 1 |
| Brogmus, KE; Lesch, A | 1 |
| Beauchamp, G; Elie, R; Lavoie, PA | 1 |
| Hauger, B; König, F; Löble, M; Wolfersdorf, M; Wössner, S | 1 |
1 review(s) available for maprotiline and trimipramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for maprotiline and trimipramine
| Article | Year |
|---|---|
Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
Topics: Adult; Ambulatory Care; Anthracenes; Anti-Anxiety Agents; Blood Pressure; Body Weight; Cardiovascular System; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Electrocardiography; Female; Heart Rate; Humans; Male; Maprotiline; Personality Inventory; Psychiatric Status Rating Scales; Pulse; Sleep; Trimipramine; Xerostomia | 1985 |
Evaluating the effectiveness of the new antidepressants.
Topics: Amoxapine; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Humans; Maprotiline; Trazodone; Trimipramine | 1983 |
Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Trimipramine | 1997 |
19 other study(ies) available for maprotiline and trimipramine
| Article | Year |
|---|---|
Development of predictive retention-activity relationship models of tricyclic antidepressants by micellar liquid chromatography.
Topics: Adenylyl Cyclase Inhibitors; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Chromatography, Liquid; Enzyme Inhibitors; Histamine H1 Antagonists; Micelles; Models, Biological; Norepinephrine; Rats; Receptors, Adrenergic, alpha-1; Selective Serotonin Reuptake Inhibitors; Serotonin; Structure-Activity Relationship | 1999 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Inhibition of N-type calcium ion channels by tricyclic antidepressants - experimental and theoretical justification for their use for neuropathic pain.
Topics: | 2022 |
Effects of antidepressants on alcohol-induced gastric mucosal injury in rats.
Topics: Amitriptyline; Animals; Antidepressive Agents; Chlorpheniramine; Cimetidine; Ethanol; Female; Gastric Mucosa; Maprotiline; Mianserin; Rats; Rats, Inbred Strains; Stomach Ulcer; Trimipramine | 1989 |
Selectivity in the binding of psychotropic drugs to the variants of alpha-1 acid glycoprotein.
Topics: Amitriptyline; Clomipramine; Desipramine; Hydrogen-Ion Concentration; Imipramine; Maprotiline; Methadone; Orosomucoid; Psychotropic Drugs; Thioridazine; Trimipramine | 1988 |
Use of tricyclic antidepressants in a patient with malignant hyperthermia.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Female; Humans; Malignant Hyperthermia; Maprotiline; Trimipramine | 1987 |
Effects of subchronic administration of psychoactive substances on the circadian rhythm of urinary corticosterone excretion in rats.
Topics: Animals; Antidepressive Agents; Circadian Rhythm; Clorgyline; Corticosterone; Fluoxetine; Imipramine; Male; Maprotiline; Pargyline; Propylamines; Rats; Trimipramine | 1985 |
Recently introduced antidepressants: their place in clinical practice.
Topics: Amoxapine; Antidepressive Agents; Bundle of His; Chemical Phenomena; Chemistry; Depressive Disorder; Electrocardiography; Erythema; Heart Rate; Humans; Maprotiline; Trazodone; Tremor; Trimipramine | 1982 |
Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus.
Topics: Animals; Antidepressive Agents; Benzamides; Desipramine; Electric Stimulation; Fluoxetine; Hippocampus; In Vitro Techniques; Male; Maprotiline; Moclobemide; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Trimipramine | 1994 |
[Psychotropic drug-induced myoclonus].
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Clozapine; Depressive Disorder; Dose-Response Relationship, Drug; Electroencephalography; Epilepsies, Myoclonic; Evoked Potentials; Female; Humans; Male; Maprotiline; Middle Aged; Psychotic Disorders; Trimipramine | 1995 |
Effect of some stereoisomeric tricyclic antidepressants on 45Ca uptake in synaptosomes from rat hippocampus.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Calcium; Calcium Channels; Calcium Radioisotopes; Doxepin; Hippocampus; In Vitro Techniques; Male; Maprotiline; Rats; Rats, Sprague-Dawley; Sodium; Stereoisomerism; Synaptosomes; Trimipramine | 1993 |